The results showed that the expression of p-Smad2/3 was significantly up-regulated after CCl4-induced liver fibrosis and was attenuated by indirubin treatment in a dose-dependent manner (Figure 5A). This evidence concerns the gene SMAD2 and Hepatic fibrosis.